Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Heim-Duthoy

K.L.

, Caperton

E.M.

, Pollock

, Matzke

G.R.

, Enthoven

, Peterson

P.K.

Apparent biliary pseudolithiasis during ceftriaxone therapy.

Antimicrob agents Chemother 1990; 34: 1146–9.

Shaad

U.B.

, Tschaeppeler

, Lentze

Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy.

Pediatr Infect Dis 1986; 5: 708–10.

Pigrau

, Pahissa

, Gropper

, Sureda

, Martinez-Vazquez

J.M.

Ceftriaxone-associated biliary pseudolithiasis in adults.

Lancet 1989; 2: 165.

Wesdorp

, Bosman

, de Graaff

, Aronson

, van der Blij

, Taminiau

Clinical presentations and predisposing factors of cholelithiasis and sludge in children.

J Pediatr Gastroenterol Nutr 2000; 31: 411–17.

Dinleyici

B.O.

, Kebapci

, Aydogdu

S.D.

Ceftriaxone-associated biliary sludge and pseudocholelithiasis during childhood: a prospective study.

Pediatr Int 2004; 46: 322–4.

Zimmerman

A.E.

, Katona

B.G.

, Jodhka

J.S.

, Williams

R.B.

Ceftriaxone-induced pancreatitis.

Ann Pharmacother 1993; 27: 36–7.

Araz

N.C.

, Demirci

Ceftazidime-associated biliary sludge in neonatal sepsis: a first report.

J Chemother 2009; 21: 703–4.

Kirejczyk

W.M.

, Crowe

H.M.

, Mackay

I.M.

, Quintiliani

, Cronin

E.B.

Disappearing “gallstones”: biliary pseudolithiasis complicating ceftriaxone therapy.

AJR Am J Roentgenol 1992; 159: 329–30.

Ceftriaxone-Associated Gallbladder Pseudolithiasis in a PD Patient

Abstract

Get full access to this article

References